CONMED Corporation Announces Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
CONMED (CNMD) PT Raised to $158 at Needham & Company
October 28, 2021 6:22 AM EDTNeedham & Company analyst Mike Matson raised the price target on CONMED (NASDAQ: CNMD) to $158.00 (from $150.00) while maintaining a Buy rating.
The analyst commented, "CNMD's 3Q21 revenue missed and EPS beat consensus. Management guided to the low-end of its prior revenue guidance range and... More
Conmed (CNMD) Tops Q3 EPS by 4c
October 27, 2021 4:24 PM EDTConmed (NASDAQ: CNMD) reported Q3 EPS of $0.80, $0.04 better than the analyst estimate of $0.76. Revenue for the quarter came in at $248.8 million versus the consensus estimate of $255.53 million.
GUIDANCE:
Conmed sees FY2021 EPS of $3.18-$3.23, versus the consensus of $3.19.
For earnings history and earnings-related data on Conmed (CNMD) click here.
... More